Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,577 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06382519Recruiting
Thalidomide for Very Early-Onset IBD in Kids
This study tests whether the drug thalidomide can help children with very early-onset inflammatory bowel disease (VEOIBD) when their symptoms are moderate to severe. It aims to see if thalidomide can calm the inflammation and improve quality of life.
Shanghai, Shanghai MunicipalityAges 4 weeks–6 years - NCT07065162Recruiting
Touch and breathing exercises for COPD
This trial tests two techniques—a gentle touch method and a breathing exercise routine—to see which helps people with mild to moderate COPD feel better and breathe easier.
Lahore, Punjab ProvinceAges 45–65 - NCT07067905RecruitingEarly Phase 1
PET scan test for glioblastoma and kidney cancer
This trial tests a new PET scan tracer called [68Ga]Ga-XT771 to see if it can better detect glioblastoma (a type of brain tumor) and clear cell renal cell carcinoma (a type of kidney cancer). If you have one of these cancers, this scan might help your doctor see the tumor more clearly.
BeijingAges 18 years+ - NCT07067229Recruiting
Brain stimulation and exercise for motor neuron disease
This study tests whether combining non-invasive brain stimulation (a gentle, non-surgical treatment) with exercise can help people with motor neuron disease (MND). It may improve movement and quality of life for those with mild to moderate symptoms.
Bangkok, PathumwanAges 18–80 - NCT07072702Recruiting
Online program to reduce unfairness feelings after work injury
This study tests an online program to help people who feel a strong sense of unfairness after a work-related back or neck injury. It aims to see if the program is helpful and practical for people early in their recovery.
Montreal, QuebecAges 25–65 - NCT07072858Recruiting
Heart MRI to Predict Recovery After Heart Attack
This study is testing if a special heart MRI taken within a week of a STEMI heart attack can help doctors predict your recovery and future risks. It may help tailor your follow-up care.
BeijingAges 18–80 - NCT07074418RecruitingPhase 4
Empagliflozin for advanced kidney disease in type 2 diabetes
This trial tests a medicine called empagliflozin (usually used for diabetes) to see if it can help people with very advanced kidney disease and diabetes. The study will check if this drug can slow down further kidney damage and improve overall kidney health.
Nice, Alpes-MaritimesAges 18–80 - NCT07067398Recruiting
Heart health program for home health aides
This study tests a program to help home health aides improve their heart health through coaching and support. Participants will get health checks and work with a peer coach to make healthy changes.
New York, New YorkAges 18 years+ - NCT07068490Recruiting
Potassium blocker study for heart stent patients
This study looks at whether a type of stomach acid medication called PCAB can help people who have had a heart stent and take blood thinners. It checks if PCAB is safe and reduces stomach bleeding.
SeoulAges 18 years+ - NCT07072247RecruitingPhase 1
RN1201 injection for hard-to-treat antibody-mediated blood disorders
This trial tests a new injection called RN1201 for people with antibody-mediated diseases, specifically two types of blood disorders: platelet transfusion refractoriness (PTR) and immune thrombocytopenia (ITP) that haven't responded to standard treatments. The goal is to see if RN1201 can help control these conditions.
Suzhou, JiangsuAges 16–65 - NCT07075653Recruiting
Barriers to vegetarian diets
This study explores the reasons why people may or may not follow a vegetarian diet. It may help researchers understand common barriers and find ways to support healthier eating.
Baltimore, MarylandAges 18–88 - NCT07071961RecruitingPhase 2
Treatment for colorectal cancer with signs of remaining disease after therapy
This trial tests a combination of two drugs, regorafenib and lorigerlimab, for people with colorectal cancer that has a positive blood test for cancer DNA after they have finished standard treatments. The goal is to see if this treatment can delay or prevent the cancer from coming back.
Houston, TexasAges 18 years+ - NCT07065747Recruiting
Understanding inflammation in uveitis using advanced eye imaging
This study uses a special eye scan (OCT) to measure and classify inflammatory cells inside the eye. It aims to better understand different types of uveitis and improve diagnosis and treatment.
Portland, OregonAges 5–85 - NCT07069127Recruiting
Home treatment for tooth sensitivity in celiac disease
This study tests a special toothpaste-like treatment for adults with celiac disease who have sensitive teeth and enamel problems. You apply it at home, and it may help reduce tooth pain and protect your teeth.
Pavia, LombardyAges 18 years+ - NCT07068776Recruiting
Shockwave therapy to improve leg wound healing after bypass surgery
This trial tests if using shockwave therapy on leg veins during coronary artery bypass surgery can help the leg wound heal better. It may be a good fit if you need 2 or more vein grafts and have stable kidney function.
Innsbruck, TyrolAges 18 years+ - NCT07070466RecruitingPhase 2
Ivonescimab with chemotherapy for advanced stomach or esophageal cancer
This study tests a new drug called ivonescimab combined with standard chemotherapy (FOLFOX) for people with advanced adenocarcinoma of the esophagus, stomach, or gastroesophageal junction. The drug is designed to help the immune system fight cancer. The study is for people who have not had prior treatment for stage IV disease and whose cancer is HER2 negative.
Santa Monica, CaliforniaAges 18 years+ - NCT07069140Recruiting
Lactoferrin mouthwash for gum health during pregnancy
This study tests if a daily lactoferrin mouthwash can improve gum health in pregnant women with gum disease, without needing antibiotics or other treatments. Researchers want to see if this natural protein helps keep gums healthier during the second trimester.
Pavia, LombardyAges 18–45 - NCT07071181Recruiting
Milk-based drinks for better sleep and health
This trial tests whether drinking a milk-based drink every day for four weeks can improve gut health, sleep quality, and heart health. It may be a good option if you have trouble sleeping and are overweight.
Leeds, West YorkshireAges 40–70 - NCT07072689Recruiting
Testing a new blood pressure cuff for young people
This study tests a new cuffless blood pressure device (Hilo Band) in young people aged 14 to 35. It compares the device's readings with a standard 24-hour blood pressure monitor to see if it is accurate and easy to use.
BellinzonaAges 14–35 - NCT07069400Recruiting
Observational study of adults with acute infection
This study observes adults hospitalized with a new or recent infection (symptoms started within 30 days). The goal is to learn more about how infections affect people in the hospital, without testing any new drugs or treatments.
Tucson, ArizonaAges 18 years+ - NCT07065708Recruiting
Ultrasound-guided pelvic floor training for new mothers
This trial tests if using a special ultrasound to show pelvic floor muscle movement during exercises helps new mothers strengthen their pelvic floor better than standard therapy alone. It is for women who gave birth vaginally within the past 4 months.
SingaporeAges 21–45 - NCT07074093Enrolling by invitation
Smartphone app to help COPD patients with air pollution
This study tests whether a smartphone app can help people with COPD breathe better by giving them tips to avoid air pollution. If you live in Salamanca and can use a smartphone, this app might help you manage your condition.
Salamanca, SalamancaAges 18 years+ - NCT07068789Recruiting
Leg Artery Bypass: One vs. Multiple Vessels for Severe Limb Threat
This trial compares opening up one versus multiple blood vessels below the knee to improve blood flow in people with severe leg pain or wounds. It aims to find the best approach to save the limb and improve quality of life.
Sohag, Sohag GovernorateAges 40 years+ - NCT07072026Recruiting
Opening blocked arteries in the brain long after stroke
This trial looks back at patients who had a procedure to reopen a major artery in the brain that had been blocked for a long time. It will help doctors learn if this treatment is safe and effective for people with chronic blockages in certain key arteries.
EssenAges 18 years+
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,577 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.